Skip to main content
. 2020 May 5;44(8):905–914. doi: 10.1093/jat/bkaa043

Table I.

MRM Transitions, Cone Voltages, Collision Energies and Retention Times for Compounds and Internal Standards (IS)

Compound MRM transitions (m/z) Cone voltage (V) Collision energy (eV) Retention time (min) IS used
Clonazolam 354.0 > 308.0/326.0 40 20 2.11 Etizolam-d3/ nitrazepam-d5
Diclazepam 321.0 > 154.0/227.0 40 31/33 5.38 Diclazepam-d4/ nitrazepam-d5
Etizolam 343.0 > 314.0/206.0 40 26/24 3.99 Etizolam-d3/ nitrazepam-d5
Flualprazolam 327.2 > 299.1/292.1 45 25 3.80a (2.81)b Diazepam-d5
Flubromazepam 335.0 > 186.0/179.0 45 45/40 3.67 Flunitrazepam-d7
Flubromazolam 371.0 > 292.0/343.0 60 31/37 3.06 Etizolam-d3/ nitrazepam-d5
Phenazepam 351.1 > 179.1/206.1 50 40/37 4.24 Flunitrazepam-d7
Diazepam-d5 290.1 > 198.1 40 30 4.24a
Diclazepam-d4 325.0 > 154.0 40 30 5.33
Etizolam-d3 348.0 > 319.0 40 24 3.97
Flunitrazepam-d7 321.1 > 275.1 35 25 3.05
Nitrazepam-d5 287.0 > 185.0 50 30 2.25
a

Flualprazolam and diazepam-d5 were analysed with a different method than the other compounds given in the table.

b

Flualprazolam has been added to the same method as the other compounds at a later date, and the corresponding retention time is given in parenthesis for comparison.